NPC
AMRI

National Planning Corporation’s Albany Molecular Research Inc AMRI Stock Holding History

National Planning Corporation’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-300
Closed -$4.8K – 2464
2014
Q4 		$4.8K Buy
+300
New +$5.51K ﹤0.01% 2336

Other funds holding AMRI

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

National Planning Corporation's AMRI Position: Q1 2015 in Review

National Planning Corporation sold out of Albany Molecular Research Inc (AMRI) in Q1 2015, closing a stake of 300 shares — an estimated $4.8K sold.

National Planning Corporation first reported a position in AMRI in Q4 2014 and held it in 1 quarter. The position peaked at $4.8K in Q4 2014. 131 funds tracked by Wall St. Rank hold AMRI as of Q1 2015.

  • National Planning Corporation reported no remaining Albany Molecular Research Inc position as of Q1 2015 after selling out during the quarter.
  • National Planning Corporation sold 300 Albany Molecular Research Inc shares in Q1 2015, an estimated $4.8K.
  • National Planning Corporation first reported a position in Albany Molecular Research Inc in Q4 2014 and held it in 1 quarter.
  • National Planning Corporation's Albany Molecular Research Inc position peaked at $4.8K in Q4 2014.
  • 131 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2015.

Based on National Planning Corporation's 13F filing for Q1 2015, filed 12 May 2015.